News – Page 380 – Endpoints News

Simultaneous advice from FDA and EMA? Very few companies go that route with new drugs, review finds

3 years ago

Manufacturing roundup: GenSight terminates batch of gene therapy; Evonik opens lipid production site in Germany

3 years ago

Apotex issues recall of eye treatment over cracked bottle caps

3 years ago

Sandoz to expand its presence in Slovenia with new $400M plant

3 years ago

UMass medical school’s manufacturing unit lays off 26 employees

3 years ago

AstraZeneca touts PhIII event-free survival win with Imfinzi

3 years ago

Coherus BioSciences lays off 20% of staff, while antimicrobial biotech makes deeper cuts

3 years ago

Neoleukin sends 70% of staff packing as IL-2 biotech searches for sale or other exit

3 years ago

Fresh Tracks considers options to stay afloat and develop autoimmune candidates

3 years ago

Flagship biotech 'Rings' in $85M+ for next-gen gene therapy effort

3 years ago

Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial

3 years ago

Ten years later, Lilly's long-term Alzheimer's trial of solanezumab has definitively failed

3 years ago

Short supply of commonly used cancer drugs raises concerns among hospital pharmacists

3 years ago

ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies

3 years ago

Industry advocates urge Senate health committee leaders to support antimicrobial pricing reform

3 years ago

FDA raises questions in adcomm briefing docs for Roche's Polivy label expansion

3 years ago

Organon doubles down on mission to prevent unplanned pregnancies with $30M investment

3 years ago

An eye, 15 seconds and striking animation: How Horizon's thyroid eye disease campaign hit home with patients

3 years ago

Novartis CEO takes pay cut as AbbVie's Rick Gonzalez nabs nearly 10% raise

3 years ago

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site

3 years ago

FDA says no adcomm planned for Biogen, Sage's depression drug

3 years ago

BioMarin seeks label expansion for achondroplasia drug; FDA lifts Inhibikase full clinical hold

3 years ago

Mesoblast’s aGVHD cell therapy will get another shot at the FDA

3 years ago

Ex-NIH, Sanofi leaders nab Merck support for their biotech’s Epstein-Barr vaccine

3 years ago

First page Previous page 377 378 379380381 382 383 Next page Last page